Kevin McKee

Kevin McKee is the VP and Global Head of Portfolio Management at CSL Behring, where they collaborate with multiple business units and enabling functions to oversee the enterprise portfolio of projects and initiatives. With extensive leadership experience in the pharmaceutical industry, Kevin previously held multiple executive roles at Merck, including leading the manufacturing transition management office for the Organon spin-off. Kevin's career also includes significant positions at JDSU and Photocircuits Corporation. They are currently pursuing an MBA in Finance at New York University and a degree in Mechanical Engineering from Villanova University.